36. Saunders PR, Kosecka U, McKay DM, Perdue MH (1994) Acute stressors stimulate ion secretion and increase epithelial permeability in rat intestine. Am J Physiol 267: G794–799. 37. Santos J, Saunders PR, Hanssen NP, Yang PC, Yates D, et al. (1999) Corticotropin-releasing hormone mimics stress-induced colonic epithelial pathophysiology in the rat. Am J Physiol 277: G391–399. 38. Park CH, Joo YE, Choi SK, Rew JS, Kim SJ, et al. (2003) Activated mast cells infiltrate in close proximity to enteric nerves in diarrhea-predominant irritable bowel syndrome. J Korean Med Sci 18: 204–210. 39. Yuan PQ, Million M, Wu SV, Rivier J, Tache Y (2007) Peripheral corticotropin releasing factor (CRF) and a novel CRF1 receptor agonist, stressin1-A activate CRF1 receptor expressing cholinergic and nitrergic myenteric neurons selectively in the colon of conscious rats. Neurogastroenterol Motil 19: 923–936. 40. Gourcerol G, Wu SV, Yuan PQ, Pham H, Miampamba M, et al. (2011) Activation of Corticotropin-Releasing Factor Receptor 2 Mediates the Colonic Motor Coping Response to Acute Stress in Rodents. Gastroenterology 140: 1586-U1313. 41. Cao J, Cetrulo CL, Theoharides TC (2006) Corticotropin-releasing hormone induces vascular endothelial growth factor release from human mast cells via the cAMP/protein kinase A/p38 mitogen-activated protein kinase pathway. Mol Pharmacol 69: 998–1006. 42. Moeser AJ, Ryan KA, Nighot PK, Blikslager AT (2007) Gastrointestinal dysfunction induced by early weaning is attenuated by delayed weaning and mast cell blockade in pigs. Am J Physiol Gastrointest Liver Physiol 293: G413– 421. Mechanisms of CRF-Induced Intestinal Dysfunction 43. Kulka M, Sheen CH, Tancowny BP, Grammer LC, Schleimer RP (2008) Neuropeptides activate human mast cell degranulation and chemokine production. Immunology 123: 398–410. 44. Raithel M, Schneider HT, Hahn EG (1999) Effect of substance P on histamine secretion from gut mucosa in inflammatory bowel disease. Scand J Gastroenterol 34: 496–503. 45. Asadi S, Alysandratos KD, Angelidou A, Miniati A, Sismanopoulos N, et al. (2012) Substance P (SP) Induces Expression of Functional Corticotropin- Releasing Hormone Receptor-1 (CRHR-1) in Human Mast Cells. J Invest Dermatol 132: 324–329. 46. Agelaki S, Tsatsanis C, Gravanis A, Margioris AN (2002) Corticotropin- releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in mice. Infection and Immunity 70: 6068–6074. 47. Venihaki M, Gravanis A, Margioris AN (1997) Comparative study between normal rat chromaffin and PC12 rat pheochromocytoma cells: Production and effects of corticotropin-releasing hormone. Endocrinology 138: 698–704. 48. Zoumakis E, Chatzaki E, Charalampopoulos I, Margioris AN, Angelakis E, et al. (2001) Cycle and age-related changes in corticotropin-releasing hormone levels in human endometrium and ovaries. Gynecological Endocrinology 15: 98–102. 49. Argenzio RA, Henrikson CK, Liacos JA (1988) Restitution of barrier and transport function of porcine colon after acute mucosal injury. Am J Physiol 255: G62–71. 50. Argenzio RA, Liacos JA (1990) Endogenous prostanoids control ion transport across neonatal porcine ileum in vitro. Am J Vet Res 51: 747–751. 51. Johnson DA, (2006) Human Mast Cell Proteases. In: Mast Cells: Methods and Protocols. Totowa, New Jersey: Humana Press pp193–202. PLoS ONE | www.plosone.org 9 June 2012 | Volume 7 | Issue 6 | e39935